Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP431581.RA_uKWx94V0HrM7vbkeceakKyin-_09SdCKbgh2rhsPzQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP431581.RA_uKWx94V0HrM7vbkeceakKyin-_09SdCKbgh2rhsPzQ130_assertion type Assertion NP431581.RA_uKWx94V0HrM7vbkeceakKyin-_09SdCKbgh2rhsPzQ130_head.
- NP431581.RA_uKWx94V0HrM7vbkeceakKyin-_09SdCKbgh2rhsPzQ130_assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP431581.RA_uKWx94V0HrM7vbkeceakKyin-_09SdCKbgh2rhsPzQ130_provenance.
- NP431581.RA_uKWx94V0HrM7vbkeceakKyin-_09SdCKbgh2rhsPzQ130_assertion evidence source_evidence_literature NP431581.RA_uKWx94V0HrM7vbkeceakKyin-_09SdCKbgh2rhsPzQ130_provenance.
- NP431581.RA_uKWx94V0HrM7vbkeceakKyin-_09SdCKbgh2rhsPzQ130_assertion SIO_000772 21289371 NP431581.RA_uKWx94V0HrM7vbkeceakKyin-_09SdCKbgh2rhsPzQ130_provenance.
- NP431581.RA_uKWx94V0HrM7vbkeceakKyin-_09SdCKbgh2rhsPzQ130_assertion wasDerivedFrom befree-20140225 NP431581.RA_uKWx94V0HrM7vbkeceakKyin-_09SdCKbgh2rhsPzQ130_provenance.
- NP431581.RA_uKWx94V0HrM7vbkeceakKyin-_09SdCKbgh2rhsPzQ130_assertion wasGeneratedBy ECO_0000203 NP431581.RA_uKWx94V0HrM7vbkeceakKyin-_09SdCKbgh2rhsPzQ130_provenance.